GROUP ONE TRADING, L.P. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 120 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$351,937
+89.2%
9,213
+78.7%
0.00%0.0%
Q2 2023$185,977
+367.8%
5,156
+395.3%
0.00%
Q1 2023$39,756
-73.7%
1,041
-89.3%
0.00%
-100.0%
Q3 2019$151,000
-55.8%
9,752
-58.3%
0.00%
-66.7%
Q4 2018$342,000
-76.7%
23,364
-71.1%
0.00%
-75.0%
Q3 2018$1,467,000
+85.2%
80,733
+71.9%
0.01%
+71.4%
Q2 2018$792,000
+89.0%
46,976
+119.8%
0.01%
+75.0%
Q1 2018$419,000
-21.2%
21,372
-51.5%
0.00%
-33.3%
Q3 2016$532,000
+9.7%
44,038
-21.6%
0.01%0.0%
Q2 2016$485,000
-13.1%
56,181
-4.7%
0.01%
-25.0%
Q1 2016$558,000
-78.7%
58,962
-60.9%
0.01%
-74.2%
Q4 2015$2,616,000
+4.3%
150,966
-19.2%
0.03%
-11.4%
Q3 2015$2,509,000
-14.9%
186,787
+43.0%
0.04%
-14.6%
Q2 2015$2,950,000
+71.8%
130,655
+8.7%
0.04%
+51.9%
Q1 2015$1,717,000
+2019.8%
120,247
+1334.4%
0.03%
+2600.0%
Q4 2014$81,000
-84.5%
8,383
-84.2%
0.00%
-87.5%
Q2 2014$524,000
-13.7%
53,064
+11.0%
0.01%
-20.0%
Q1 2014$607,000
-80.2%
47,789
-76.7%
0.01%
-78.3%
Q4 2013$3,073,000
+36.6%
204,984
+0.6%
0.05%
+7.0%
Q3 2013$2,249,000
+254.2%
203,727
+155.1%
0.04%
+168.8%
Q2 2013$635,00079,8700.02%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders